The Impact of COVID-19 Pandemic on Lung Cancer Community

Since the outbreak of 2019 novel coronavirus disease (COVID-19) induced by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic has become a global catastrophe. Patients with cancer especially lung cancer are more vulnerable and susceptible to get infected by the virus SARS-CoV-2. The overwhelming impact of COVID-19 on lung cancer community may result in rise of the incidence and mortality of lung cancer. It would become more obvious in future retrospective studies. Lung cancer patients are believed at higher risk of COVID-19 due to immunosuppression and should be protected by vaccination with priority. Better understanding of SARS-CoV-2 could help develop more effective vaccines to eradicate this disease in the near future.

Automated summary

The COVID-19 pandemic has significantly impacted lung cancer patients, who are believed to be at higher risk of infection and could see an increase in incidence and mortality. Vaccination is crucial for protecting lung cancer patients, and a better understanding of the SARS-CoV-2 virus could lead to the development of more effective vaccines in the future.